News Center

Discover all of the trending news of the Ipsen Group


157 results

Oncology

It’s time to talk about kidney cancer!

17 June 2019

World Kidney Cancer Day is on 20 June, an event created by the International Kidney…

Innovation

How Ipsen is making patient-centric innovation a reality

31 May 2019

Bartek Bednarz, Ipsen, Senior Vice-President, Oncology Franchise The world of healthcare is changing. Patients are…

Event

Ipsen – Investor Day 2019

13 May 2019

To register for the webcast, please Click here.

Patient

Standby statement on lanreotide generic

29 April 2019

Paris (France), April 29, 2019 - Following information regarding the filing of a generic…

Financial information

Ipsen – 2019 First Quarter results – April 24, 2...

23 April 2019

To register for the webcast, please Click here.

Group

Ipsen completes acquisition of Clementia Pharmaceuticals

18 April 2019

Today, Ipsen announced the closing of the acquisition of Clementia Pharmaceuticals. A Canadian clinical-stage biotech…

Event

Ipsen is present at ESGE Days with an educational symposium ...

04 April 2019

ESGE DAYS 2019 is the second edition of a congress dedicated to increasing quality of…

Group

Building the market access ecosystem

13 March 2019

At Eyeforpharma 2019, Ipsen’s Senior VP Market Access, Ulf Staginnus is participating in a…

CSR

Ipsen champions women in leadership and gender equality this...

08 March 2019

International Women’s Day is a great opportunity to celebrate our extraordinary female colleagues around the…

Group

Ipsen acquisition of Clementia Pharmaceuticals – Confe...

25 February 2019

Ipsen will host a conference call and web conference today to discuss this announcement. Participants…

Financial information

Ipsen reiterated its commitment to the Innobio-2 fund

06 February 2019

On February 4, 2019, Ipsen was delighted to attend the presentation of the new CSF…

Group

Ipsen commits to making all its published scientific researc...

22 January 2019

We aim to publish the results of our clinical studies in peer-reviewed medical and scientific…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023